MTLS Materialise NV
Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software…
Industry Peers
Software - Application
SHOPSHOPSHOP| Headline | Source | Time |
|---|---|---|
Older | ||
European Equities Traded in the US as American Depositary Receipts Start Week Slightly Lower in Monday Trading European equities traded in the US as American depositary receipts opened the week tracking slightly | ||
European Equities Traded in the US as American Depositary Receipts Drop in Thursday Trading European equities traded in the US as American depositary receipts were trending lower late Thursday | ||
European Equities Traded in the US as American Depositary Receipts Marginally Higher in Friday Trading European equities traded in the US as American depositary receipts were marginally higher late Frida | ||
European Equities Traded in the US as American Depositary Receipts Edge Lower in Monday Trading European equities traded in the US as American depositary receipts opened the week slightly lower la | ||
 Materialise (MTLS) Q2 2026 Earnings Call Transcript Medical revenue surged 9.6% while management raised full-year profit guidance. | ||
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading European equities traded in the US as American depositary receipts were marginally higher late Frida | ||
Materialise NV (MTLS) (Q2 2026) Earnings Call Highlights: Medical Growth and Aerospace Surge ... Materialise NV (MTLS) raises full-year adjusted EBIT guidance amid strong Medical segment performance and a 40% surge in Aerospace revenue. | ||
European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading European equities traded in the US as American depositary receipts were trending lower late Thursday | ||
 Materialise Q2 Earnings Call Highlights Materialise (NASDAQ:MTLS) reported second-quarter revenue growth of more than 8% year over year to €70.1 million, driven by double-digit expansion in its Medical segment and continued improvement in profitability. The company raised its full-year adjusted EBIT outlook while maintaining its revenue g | ||
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading European equities traded in the US as American depositary receipts were tracking lower late Wednesda | ||
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading European equities traded in the US as American depositary receipts started the week off lower late M | ||
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading European equities traded in the US as American depositary receipts were climbing sharply higher late | ||
European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading European equities traded in the US as American depositary receipts were lower late Tuesday morning, | ||